Scrip
Proximagen shores up business with £50 million placing
05 June 2009
Simon Varcoe
Proximagen Neuroscience, the UK biopharmaceutical company, is to raise £50 million through the placement of nearly 36 million new ordinary shares of 1 pence each at a price of £1.40 per share.
The fundraising is one of the largest that the UK biotech sector has seen for many years....
Please Login to read the full article.
05 June 2009
Simon Varcoe
The fundraising is one of the largest that the UK biotech sector has seen for many years....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
